Skip to content

Clinical trials

Peanut Hypersensitivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peanut Hypersensitivity Clear all

164 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20064
20072
20082
20095
20107
20115
20124
201311
20149
201511
20168
201712
201811
201910
20206
202110
202210
20237
20243
20257
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed93
Recruiting18
Unknown status14
Terminated14
Active, not recruiting10
Withdrawn6
Not yet recruiting5
No longer available1
Suspended1
Enrolling by invitation1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
DBV Technologies13
University of North Carolina, Chapel Hill13
National Institute of Allergy and Infectious Diseases (NIAID)12
Aimmune Therapeutics, Inc.10
Johns Hopkins University7
Massachusetts General Hospital5
Novartis Pharmaceuticals5
Medical University of Warsaw4
University Hospital, Montpellier4
Imperial College London3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peanut Hypersensitivity164
Food Hypersensitivity75
Hypersensitivity37
Nut Hypersensitivity16
Anaphylaxis12
Egg Hypersensitivity12
Hypersensitivity, Immediate11
Milk Hypersensitivity10
Dermatitis, Atopic4
Immune System Diseases4

Trials

Showing 26 to 50 of 164. Each trial links to its page on Pharma Observatory.

64 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.